Sasapyrine powder Raw Materials CAS 552-94-3
Sasapyrine powder Raw Materials CAS 552-94-3
Sasapyrine powder Raw Materials CAS 552-94-3
Sasapyrine powder Raw Materials CAS 552-94-3
Home > Organic Raw Materials

Sasapyrine powder Raw Materials CAS 552-94-3

Related Attributes


Product details

Uses and synthesis of Sasapyrine powder.

Sasapyrine powder is a head-to-tail salicylic acid dimer that does not stimulate gastric mucosa and has no inhibitory effect on platelets. Salicylic acid drugs are common non-steroidal anti-inflammatory drugs. Sasapyrine is widely used as antipyretic, analgesic, anti-inflammatory and anti-rheumatic drugs, and its effects on lowering blood sugar and preventing and treating thrombotic diseases have also attracted attention.

Osteoarthritis: Relieve pain, swelling and stiffness caused by osteoarthritis.

Rheumatoid Arthritis: Relieve inflammation and pain symptoms of rheumatoid arthritis.

Other arthritis and joint diseases: For example, acute attacks of ankylosing spondylitis and gouty arthritis.

Musculoskeletal pain: For example, muscle strains, sprains, low back pain, tenosynovitis, etc.

Mild to moderate pain: For example, headaches, toothaches, dysmenorrhea, etc.

Sasapyrine powder

Sasapyrine Drug Interactions.

With other NSAIDs (including aspirin): Co-use may increase the risk of gastrointestinal bleeding, kidney damage, etc., and should be avoided.

Anticoagulants (such as warfarin, heparin): Although Sasapyrine itself has a weak effect on platelet aggregation, it may still increase the risk of bleeding. Caution should be exercised when used in combination, and coagulation indicators should be monitored.

Glucocorticoids: Co-use may increase the risk of gastrointestinal ulcers and bleeding.

Selective serotonin reuptake inhibitor (SSRI) antidepressants: Co-use may increase the risk of gastrointestinal bleeding.

Diuretics: NSAIDs may reduce the diuretic effect of diuretics and increase the risk of kidney damage.

Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB): NSAIDs may reduce the antihypertensive effect and increase the risk of kidney damage.

Digoxin: NSAIDs may increase digoxin blood concentrations and increase the risk of digoxin toxicity.

Lithium: NSAIDs may increase lithium blood concentrations and increase the risk of lithium toxicity.

Methotrexate: NSAIDs may inhibit the excretion of methotrexate and increase the risk of methotrexate toxicity.

 

Sasapyrine


Why choose us?

factory

HRK Factory

HRK Factory

About Shipping

shipping

Prev: Sennoside A powder Raw Materials CAS 81-27-6 Next: 3-Mercaptopropyltriethoxysilane liquid Raw Materials CAS 14814-09-6

Pharmaceutical Intermediate manufacturers

sales08@interlgroup.com

©2023 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking